Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2016 1
2017 1
2018 4
2020 1
2021 5
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ.
Ye K, Li F, Wang R, Cen T, Liu S, Zhao Z, Li R, Xu L, Zhang G, Xu Z, Deng L, Li L, Wang W, Stepanov A, Wan Y, Guo Y, Li Y, Wang Y, Tian Y, Gabibov AG, Yan Y, Zhang H. Ye K, et al. Among authors: tian y. Mol Ther. 2022 Dec 7;30(12):3658-3676. doi: 10.1016/j.ymthe.2022.06.010. Epub 2022 Jun 17. Mol Ther. 2022. PMID: 35715953 Free PMC article.
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment.
Liu S, Li F, Ma Q, Du M, Wang H, Zhu Y, Deng L, Gao W, Wang C, Liu Y, Zhao Z, Liu H, Wang R, Tian Y, Hu M, Wan Y, Lu W, Zhang M, Zhao M, Cao Y, Zhang H, Wang W, Wang H, Wang Y. Liu S, et al. Among authors: tian y. Theranostics. 2023 Jul 9;13(12):4016-4029. doi: 10.7150/thno.83495. eCollection 2023. Theranostics. 2023. PMID: 37554264 Free PMC article.
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
Fu D, Zhang G, Wang Y, Zhang Z, Hu H, Shen S, Wu J, Li B, Li X, Fang Y, Liu J, Wang Q, Zhou Y, Wang W, Li Y, Lu Z, Wang X, Nie C, Tian Y, Chen D, Wang Y, Zhou X, Wang Q, Yu F, Zhang C, Deng C, Zhou L, Guan G, Shao N, Lou Z, Deng F, Zhang H, Chen X, Wang M, Liu L, Rao Z, Guo Y. Fu D, et al. Among authors: tian y. PLoS Biol. 2021 May 7;19(5):e3001209. doi: 10.1371/journal.pbio.3001209. eCollection 2021 May. PLoS Biol. 2021. PMID: 33961621 Free PMC article.
A general Fc engineering platform for the next generation of antibody therapeutics.
Chen D, Zhao Y, Li M, Shang H, Li N, Li F, Wang W, Wang Y, Jin R, Liu S, Li X, Gao S, Tian Y, Li R, Li H, Zhang Y, Du M, Cao Y, Zhang Y, Li X, Huang Y, Hu LA, Li F, Zhang H. Chen D, et al. Among authors: tian y. Theranostics. 2021 Jan 1;11(4):1901-1917. doi: 10.7150/thno.51299. eCollection 2021. Theranostics. 2021. PMID: 33408788 Free PMC article.
23 results